Phaarmasia Limited (BOM:523620)
89.55
-0.45 (-0.50%)
At close: Sep 25, 2026
Phaarmasia Market Cap
Phaarmasia has a market cap or net worth of 611.35 million as of September 25, 2026. Its market cap has increased by 135.41% in one year.
Market Cap
611.35M
Enterprise Value
512.73M
Revenue
486.17M
Ranking
n/a
PE Ratio
3.47
Stock Price
89.55
ChartMarket Cap Chart
Since April 13, 1998, Phaarmasia's market cap has increased from 13.70M to 611.35M, an increase of 4,361.72%. That is a compound annual growth rate of 14.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 611.35M | -20.57% |
| Dec 31, 2025 | 769.67M | 132.45% |
| Dec 31, 2024 | 331.11M | 23.19% |
| Dec 29, 2023 | 268.78M | 41.36% |
| Dec 30, 2022 | 190.13M | -15.73% |
| Dec 31, 2021 | 225.63M | -8.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Parmax Pharma | 938.28M |
| Amwill Health Care | 889.76M |
| Source Natural Foods and Herbal Supplements | 701.30M |
| Onyx Biotec | 652.76M |
| Shelter Pharma | 639.80M |
| Rekvina Laboratories | 565.90M |
| Cian Healthcare | 554.50M |
| Biofil Chemicals and Pharmaceuticals | 522.06M |